News/ News/ R&D Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 trial Phil Taylor coronavirus, infectious disease, Mallinckrodt, Novoteris 0 Comment Mallinckrodt and Novoteris have been given a green light by Health Canada to start a pilot study of Share X Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 trial https://pharmaphorum.com/news/mallinckrodt-novoteris-nitric-oxide-will-start-covid-19-trial/
coronavirus, infectious disease, Mallinckrodt, Novoteris
0 Comment
